

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 90/400mg | 56 pill | β¬71.38 | β¬3,997.18 Best Price Popular | |
| 90/400mg | 28 pill | β¬85.66 | β¬2,398.54 |
Ledipasvir / Sofosbuvir is a combination medication used primarily to treat hepatitis C virus (HCV) infection. This powerful duo of antiviral agents has revolutionized hepatitis C therapy by offering a highly effective and well-tolerated option for many patients. It combines two drugs: Ledipasvir, an NS5A inhibitor, and Sofosbuvir, a nucleotide polymerase inhibitor. Together, they work synergistically to target different stages of the HCV lifecycle, leading to a significant decline in viral replication and helping to clear the infection.
Ledipasvir blocks the NS5A protein, which is essential for HCV replication and assembly. By inhibiting this protein, it prevents the virus from multiplying within the liver cells. Sofosbuvir acts by inhibiting the NS5B polymerase enzyme, which is crucial for viral RNA replication. When combined, these drugs provide a dual mechanism of action that makes it difficult for the virus to develop resistance. The treatment usually results in a cure, especially when taken as prescribed and for the appropriate duration.
Many clinical studies have shown that Ledipasvir / Sofosbuvir can achieve cure rates of over 95% in many patients with hepatitis C. The medication is effective across multiple genotypes of the virus, making it a versatile option. It is especially advantageous because it is taken once daily, which enhances patient compliance. Additionally, the treatment course is generally shorter compared to older regimens, often lasting 8 to 12 weeks. Patients who complete the full course often experience a complete viral eradication, which significantly reduces the risk of liver-related complications and improves overall health.
Although Ledipasvir / Sofosbuvir is well-tolerated by most patients, some may experience side effects. The most common include fatigue, headache, nausea, and weakness. In rare cases, patients might encounter more serious side effects like allergic reactions or liver problems. It is important to inform your healthcare provider about any unusual symptoms during the treatment. Regular monitoring through blood tests is typically recommended to ensure the medicationβs safety and effectiveness throughout the course.
Before starting Ledipasvir / Sofosbuvir, patients should disclose their complete medical history and current medications. Certain drugs and supplements can interfere with the effectiveness of the medication or increase the risk of side effects. For example, antacids should be taken with caution or separated from the medication's dosing window. Itβs also important to avoid alcohol and hepatotoxic substances during treatment. Pregnant women or women planning pregnancy should consult their healthcare provider, as safety data is limited in some populations. Monitoring kidney and liver functions is essential for patients with comorbid conditions.
Ledipasvir / Sofosbuvir remains a cornerstone in hepatitis C treatment due to its high efficacy, manageable side effect profile, and convenient dosing. For those diagnosed with hepatitis C, this medication offers a promising path toward viral elimination and improved quality of life. As with any medication, proper medical guidance and adherence to prescribed regimens are key to achieving the best possible outcomes. Patients should work closely with their healthcare providers to ensure the treatment is both safe and effective for their individual health needs.
14β21 days. Free from β¬172.81 .
5β9 days. β¬25.92
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.